GLMD Message Board, Galmed Pharmaceuticals Ltd.

A company with research centered around each of these divisions, like a cluster of trees each growing additional branches form its own trunk, will usually do much better than a company working on a number of unrelated new products which, if successful, will land it in several new industries ...

The new year has a collection of challenges in store for the biotech sector and its investors, as pressure mounts from Washington on drug pricing practices. Along with talking points surrounding the upcoming presidential election in the US, several drug approvals and research developments wi...

The NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ) rose slightly last week from 3,759.2 points on Monday’s (December 2) open to 3,763.81 points as of 11:30 a.m. EST on Friday (December 6). On Tuesday (December 3), Cara Therapeutics (NASDAQ: CARA ) released results from a Phase 2 cli...